HealthEquity Total Long-Term Assets 2014-2024 | HQY

HealthEquity total long-term assets from 2014 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • HealthEquity total long-term assets for the quarter ending July 31, 2024 were $3.019B, a 14.18% increase year-over-year.
  • HealthEquity total long-term assets for 2024 were $2.606B, a 3.68% decline from 2023.
  • HealthEquity total long-term assets for 2023 were $2.706B, a 1.81% decline from 2022.
  • HealthEquity total long-term assets for 2022 were $2.756B, a 22.47% increase from 2021.
HealthEquity Annual Total Long-Term Assets
(Millions of US $)
2024 $2,606
2023 $2,706
2022 $2,756
2021 $2,250
2020 $2,268
2019 $115
2018 $104
2017 $78
2016 $77
2015 $34
2014 $31
2013 $31
HealthEquity Quarterly Total Long-Term Assets
(Millions of US $)
2024-07-31 $3,019
2024-04-30 $2,842
2024-01-31 $2,606
2023-10-31 $2,619
2023-07-31 $2,644
2023-04-30 $2,677
2023-01-31 $2,706
2022-10-31 $2,733
2022-07-31 $2,765
2022-04-30 $2,786
2022-01-31 $2,756
2021-10-31 $2,335
2021-07-31 $2,288
2021-04-30 $2,297
2021-01-31 $2,250
2020-10-31 $2,261
2020-07-31 $2,281
2020-04-30 $2,279
2020-01-31 $2,268
2019-10-31 $2,290
2019-07-31 $245
2019-04-30 $232
2019-01-31 $115
2018-10-31 $114
2018-07-31 $115
2018-04-30 $114
2018-01-31 $104
2017-10-31 $103
2017-07-31 $91
2017-04-30 $84
2017-01-31 $78
2016-10-31 $78
2016-07-31 $77
2016-04-30 $77
2016-01-31 $77
2015-10-31 $71
2015-07-31 $35
2015-04-30 $35
2015-01-31 $34
2014-10-31 $34
2014-07-31 $35
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-01-31 $33
Sector Industry Market Cap Revenue
Medical Medical Services $8.756B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00